HIV and viral hepatitis impose a substantial health burden on sub-Saharan Africa!
Nearly 26 million people are living with HIV in the region, yet only 11 million are on treatment. HBV is highly endemic in the region, yet access to vaccination and treatment is limited. With an estimated 32 million people infected with HCV, sub-Saharan Africa has the highest burden of HCV disease in the world, yet most HCV-infected individuals lack access to treatments that can cure their disease. Building clinician capacity to optimally screen for, test, and treat people living with HIV and/or HBV and HCV is a public health priority at the center of the IAPAC African Regional Capacity-Building Hub’s mission.